EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Kintegral Advisory LLC Buys New Holdings in Moderna, Inc. $MRNA - Stock Observer
Moderna, Inc. $MRNA Shares Sold by V Square Quantitative Management LLC - Stock Observer
Healthcare Stocks To Consider - October 17th - Markets Daily
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
4,620 Shares in Moderna, Inc. $MRNA Purchased by St. Louis Financial Planners Asset Management LLC
Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA
Phase 3 Cancer Vaccine Success Could Change The Case For Moderna Stock
Moderna (NASDAQ:MRNA) Stock Price Down 7.8% After Insider Selling
Moderna (NASDAQ:MRNA) Stock: Insider Stephen Hoge Sells 39,224 Shares
Insider Selling: Moderna (NASDAQ:MRNA) President Sells 39,145 Shares of Company Stock
Insider Selling: Moderna (NASDAQ:MRNA) President Sells $8,640,084.40 in Stock - Stock Observer
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Moderna (NASDAQ:MRNA) Stock Falls 9.5% - Here's What Happened
Moderna stock sinks as Wall Street turns cautious following blistering rally
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put
Healthcare Stocks To Add to Your Watchlist - October 16th - Stock Observer
Moderna (NASDAQ:MRNA) Shares Climb 4.6% - Still a Buy? - Daily Political
15,000 Moderna, Inc. $MRNA Shares Sold by Quattro Financial Advisors LLC
NFSG Corp Purchases 5,162 Shares of Moderna, Inc. $MRNA - Markets Daily
Moderna, Inc. $MRNA Position Lifted by NFSG Corp - Stock Observer
Promising Biotech Stocks To Follow Today - October 13th - Stock Observer
'AI lowers the capital needed': India's drug discovery push faces test of human trials
Moderna (NASDAQ:MRNA) Shares Up 4.5% Following Analyst Upgrade
Moderna (NASDAQ:MRNA) Shares Climb 4.5% Following Analyst Upgrade
PFG Private Wealth Management LLC Makes New Investment in Moderna, Inc. $MRNA - Zolmax
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Moderna Stock Is Soaring on Cancer Vaccine Buzz. Is It Too Late to Get In?
Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
PFG Private Wealth Management LLC Acquires New Shares in Moderna, Inc. $MRNA - Daily Political
Healthcare Stocks To Consider - October 15th - Daily Political
Strategy Asset Managers LLC Purchases 13,021 Shares of Moderna, Inc. $MRNA
Analysts' Recent Ratings Updates for Moderna (MRNA) - Stock Observer
Moderna designs bispecific antibodies against SARS-CoV-2 variants | BioWorld
Moderna (NASDAQ:MRNA) Stock Price Up 4.6% - Time to Buy?
Merck CEO: Cancer vaccine manufacturing time could shrink
Top Healthcare Stocks To Research - October 14th - Stock Observer
Top Biotech Stocks To Research - October 14th - Stock Observer
Moderna (NASDAQ:MRNA) Hits New 52-Week High on Analyst Upgrade - Markets Daily
AI cannot replace clinical trials soon, warns Moderna co-founder Noubar Afeyan
Promising Healthcare Stocks To Keep An Eye On - October 11th - Stock Observer
Healthcare Stocks To Watch Today - October 12th - Stock Observer
Moderna, Inc. $MRNA Shares Sold by Contravisory Investment Management Inc.
Sivik Global Healthcare LLC Makes New Investment in Moderna, Inc. $MRNA
Moderna co-founder Noubar Afeyan calls for urgent regulation of AI agents
'Pharma Bro' Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks | Morningstar
Moderna (NASDAQ:MRNA) Shares Up 1.2% - Here's Why - Daily Political
Moderna Founder Calls for Urgent Regulation of AI Agents
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?
Promising Healthcare Stocks To Keep An Eye On - October 11th - Zolmax
Biotech Stocks To Watch Today - October 11th - Daily Political
Health Canada reviewing new mRNA flu vaccine that could prevent more hospitalisations
Moderna stock surges more than 600% in 2026
Merck (MRK) Could Be 7% Below Fair Value On Phase III Cancer Vaccine Results
Healthcare Stocks To Watch Today - October 12th - Markets Daily
Moderna (NASDAQ:MRNA) Reaches New 12-Month High - Still a Buy?
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?
Palantir CTO Shyam Sankar says researchers have started smoking, believing AI will cure cancer
Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week?
Moderna (MRNA) Is Up 18.4% After Cancer Vaccine Milestone And Nasdaq-100 Return Has The Bull Case Changed?
Moderna (MRNA) Stock Looks Expensive Following Its 7x One Year Run
Moderna (MRNA) Stock Sees Modest Fair Value Lift After Cancer Vaccine Analyst Revisions
Moderna Stock Surge Puts These Oncology Biotechs On Retail Investors Radar
mRNA Vaccine Hires Could Be A Game Changer For Everest Medicines (SEHK:1952)
Promising Value Stocks Worth Watching - October 10th - Zolmax
Promising Healthcare Stocks To Follow Today - October 10th - Zolmax
Top Biotech Stocks To Watch Now - October 10th - Markets Daily
Moderna (NASDAQ:MRNA) Price Target Raised to $95.00 - Zolmax
MRNA: Melanoma Success Changed The Story, The Stock Still Prices In Too Much
Moderna (MRNA) Hits New 52-Week High Amid Cancer Vaccine Buzz an
Weekly Market Update: Stocks Gain 1.03% as Utilities Rise, Industrials Fall | Morningstar
Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High - Here's Why
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
Moderna, Inc. $MRNA Shares Sold by Douglas Lane & Associates LLC
Moderna stock jumps on planned national cancer vaccine effort
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Rep. Maria Elvira Salazar Unloads Shares of Moderna, Inc. (NASDAQ:MRNA)
RBC Capital Remains a Hold on Moderna (MRNA)
Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development | Valuespectrum.com
Moderna Sheds Investor Lawsuit Over RSV Vaccine Efficacy Figure
Biotech Stocks To Keep An Eye On - October 6th - Markets Daily
AI Breakthrough: Room Temperature Storage for mRNA Vaccines, ETPharma
RGEN: Bioprocessing Growth And Vaccine Exposure Keep Future Upside Intact
RGEN: Vaccine Optimism And The BioLife Deal Leave Little Room For Error
Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets
Odd Biotech Action Is Creating Opportunities for Deal Hunters
Morgan Stanley Issues Positive Forecast for Moderna (NASDAQ:MRNA) Stock Price
Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Stock Observer
Top Healthcare Stocks To Watch Now - October 7th - Daily Political
Moderna (MRNA) Could Be 57% Above Fair Value On New COO Appointment
RGEN: Cancer Vaccine Exposure And Bioprocess Expansion Support A Stronger Outlook
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?
Moderna (NASDAQ:MRNA) Hits New 52-Week High - Time to Buy?
Paramount-Warner Bros. deal finally closes: Stocks to watch on Tuesday
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
